Internal Medicine Department
Hematology Division

Linda L. Kelley, PhD

Email:    linda.kelley@hsc.utah.edu

Education:


1984 – 1990    Ph.D. in Pathology, Vanderbilt University, Nashville, Tennessee

1981 – 1983    Darthmouth College, Hanover, New Hampshire

1977 – 1981    B.S., University of New Hampshire, Durham, New Hampshire

Training:

1989 – 1992    Post-doctoral Research Fellow in Hematology, Vanderbilt University, Nashville, Tennessee

Other:     

2003 – today     Director, Cellular Therapies, Utah Tissue and Cell – Western Division, Salt Lake City, Utah

1994 – today    Director, Hematopoietic Stem Cell Lab, Department of Internal Medicine, School of Medicine, University of Utah, Salt Lake City, Utah

1994 – today    Director, Pediatric and Adult Apheresis, Primary Children's Medical Center, University Health Care, Salt Lake City, Utah
 

Bibliography

  1. Kelley L. (2004). Commentary on 2003-808:Infusion of unwashed umbilical cord blood stem cells after thawing for allogeneic transplantation. Bone Marrow Transplantation, 34(8), 741.
  2. Kelley L. (2003). The role and activities of the ISCT regulatory affairs committee. Cytotherapy, 5(4), 279-283.
  3. Ford CD, Lehman C, Strupp A, Kelley L. (2002). Comparison of CD34+ cell collection efficiency on the COBE Spectra and Fenwall CS-3000 Plus. J Clin Apheresis, 17(1), 17-20.
  4. Prasher JM, Elenitoba-Johnson KS, Kelley LL. (2001). Loss of p53 tumor suppressor function is required for in vivo progression of Friend erythroleukemia. Oncogene, 20(23), 2946-55.
  5. Ford CD, Lehman C, Strupp A, Kelley L. (2001). Comparison of CD34+ cell collection efficiency on the COBE Spectra and Fenwall CS-3000 Plus. J Clin Apheresis.
  6. Hsieh FF, Barnett LA, Green WF, Freedman K, Matushansky I, Skoultchi AI, Kelley LL. (2000). Cell cycle exit during terminal erythroid differentiation is associated with accumulation of p27(Kip1) and inactivation of cdk2 kinase. Blood, 96(8), 2746-54.
  7. Bills A, Green W, Tsodikov A, Carey M, Perkins S, Petersen F, Beatty P, Kelley LL. (1999). Cytokeratin Positive Cells in Peripheral Blood Stem Cell Collection from Normal Donors and patients with Non Epithelial Cell-Derived Tumors. Cytotherapy, 1(5), 389-399.
  8. Kelley LL, Hicks GG, Hsieh FF, Prasher JM, Green WF, Miller MD, Eide EJ, Ruley HE. (1998). Endogenous p53 regulation and function in early stage Friend virus-induced tumor progression differs from that following DNA damage. Oncogene, 17(9), 1119-30.
  9. Warters RL, Roberts JC, Wilmore BH, Kelley LL. (1997). Modulation of radiation-induced apoptosis by thiolamines. Int J Radiat Biol, 72(4), 439-48.
  10. Koury MJ, Kelley LL, Bondurant MC. (1994). The fate of erythroid progenitor cells. Ann N Y Acad Sci, 718, 259-67; discussion 267-70.
  11. Kelley LL, Green WF, Hicks GG, Bondurant MC, Koury MJ, Ruley HE. (1994). Apoptosis in erythroid progenitors deprived of erythropoietin occurs during the G1 and S phases of the cell cycle without growth arrest or stabilization of wild-type p53. Mol Cell Biol, 14(6), 4183-92.
  12. Kelley LL, Koury MJ, Bondurant MC, Koury ST, Sawyer ST, Wickrema A. (1993). Survival or death of individual proerythroblasts results from differing erythropoietin sensitivities: a mechanism for controlled rates of erythrocyte production. Blood, 82(8), 2340-52.
  13. Kelley LL, Koury MJ, Bondurant MC. (1992). Regulation of programmed death in erythroid progenitor cells by erythropoietin: effects of calcium and of protein and RNA syntheses. J Cell Physiol, 151(3), 487-96.
  14. Stewart SJ, Cunningham GR, Strupp JA, House FS, Kelley LL, Henderson GS, Exton JH, Bocckino SB. (1991). Activation of phospholipase D: a signaling system set in motion by perturbation of the T lymphocyte antigen receptor/CD3 complex. Cell Regul, 2(10), 841-50.
  15. Kelley LL, Blackmore PF, Graber SE, Stewart SJ. (1990). Agents that raise cAMP in human T lymphocytes release an intracellular pool of calcium in the absence of inositol phosphate production. J Biol Chem, 265(29), 17657-64.
  16. Stewart SJ, Kelley LL, Powers FS. (1987). Production of inositol pentakisphosphate in a human T lymphocyte cell line. Biochem Biophys Res Commun, 145(2), 895-902.
  17. Lawe JE, Kelley LL. (1983). Study of a family with a variant M antigen. Vox Sanguinis, 44(92).
  18. Lawe JE, Kelley LL, Fogg MK. (1981). Non exclusion of paternity due to a silent Fy allele. Laboratory Medicine, 12(69).